Liver International

• Acute on Chronic Liver Failure From Novel SARS-CoV-2 The authors report on a case of acute on chronic liver failure caused by SARS-CoV-2 infection in a patient with decompensated alcoholic cirrhosis.
  Liver International, July 31, 2020
• New Insights in the Management of Hepatocellular Adenoma While benign, hepatocellular adenoma may be complicated by hemorrhage or malignant transformation to HCC. Review the latest on its epidemiology, diagnosis, prognosis and treatment in this article.
  Liver International, July 24, 2020
• The Global Epidemiology of Hepatitis E Virus Infection This study aimed to map the global prevalence of hepatitis E virus infection, as well as identify its most important risk factors.
  Liver International, July 17, 2020
• Increasing Liver Fat and Progression of CVD Risk Factors How does increasing liver fat over time impact cardiovascular risk factors such as glucose, total cholesterol, HDL, and triglycerides?
  Liver International, July 10, 2020
• Tamoxifen-related NAFLD: Prevalence, Incidence, Risk Factors How common is the development of fatty liver after tamoxifen treatment in breast cancer patients, and what are the associated risk factors?
  Liver International, July 03, 2020
• Risk Factors for Liver Injury in Non-ICU COVID-19 Patients What factors might influence the development of liver injury in non-ICU hospitalized COVID-19 patients?
  Liver International, June 26, 2020
• COVID-19 and Prevalence of Chronic Liver Disease This study examined the prevalence of chronic liver disease among patients with COVID-19, and investigated the potential relationship between COVID-19 and liver damage.
  Liver International, June 19, 2020
• Liver Injury During Highly Pathogenic Coronavirus Infections Liver injury has been reported in cases of COVID-19 as well as in MERS-CoV and SARS-CoV. What do we know regarding the characteristics and mechanism of coronavirus infection-induced liver injury?
  Liver International, May 22, 2020
• Factors Impacting Fecal Microbiome in Liver Cirrhosis Which factors have the strongest influence on fecal microbiome composition in patients with liver cirrhosis? This study examined the contribution of medications, diet, and disease severity.
  Liver International, May 13, 2020
• Diet Quality and Its Association With NAFLD and Mortality This study investigated the impact of diet on non-alcoholic fatty liver disease. Can a high quality diet lower risk of cancer-related and all-cause mortality?
  Liver International, April 29, 2020
• Liver Stiffness Measurement, Survival, Complications in NAFLD How accurate is liver stiffness measurement for predicting overall survival and liver, cardiovascular and oncologic complications in NAFLD?
  Liver International, April 16, 2020
• Global Timing of HCV Elimination in High-income Countries Are high-income countries on track to meet HCV elimination targets by 2030?
  Liver International, April 09, 2020
• Increased Cancer Rates in Patients With Chronic Hepatitis C This study shows an increased rate of several different cancer types in hepatitis C patients compared to those who do not have HCV. How does cirrhosis impact cancer incidence?
  Liver International, April 02, 2020
• Alcohol Consumption and Severity of Acute Liver Injury This study suggests that even moderate alcohol consumption increases the severity and clinical course of liver injury in acetaminophen as well as non-acetaminophen acute liver failure.
  Liver International, March 17, 2020
• PCOS Is Associated With NASH Severity and Advanced Fibrosis Does polycystic ovary syndrome influence severity of non-alcoholic fatty liver disease and risk of advanced fibrosis?
  Liver International, March 10, 2020
• NAFLD and Risk of New-onset AF in Healthy Adults This study investigated whether NAFLD is independently associated with increased risk for new-onset AF in a healthy population-based cohort.
  Liver International, March 03, 2020
• Sofosbuvir/Ledipasvir for HCV in Children Aged 3-6 Years The use of interferon-based regimens in chronic hepatitis C-infected children 3-6 years of age is limited due to side effects. Does sofosbuvir/ledipasvir therapy provide a safe alternative?
  Liver International, February 25, 2020
• Impact of Delaying DAA Treatment for Chronic Hepatitis C What is the impact of delaying treatment for different populations of people living with hepatitis C? The authors present a clinical decision tool for informing treatment timing decisions.
  Liver International, February 18, 2020
• Metabolic Syndrome, But Not NAFLD, Increases 10-year Mortality This study compared 10-year mortality among those with and without NAFLD in an urban South Asia cohort. What factors were associated with early risk of death?
  Liver International, February 11, 2020
• Assessment of Suspected Drug-induced Liver Injury Accurate and rapid diagnosis of suspected drug-induced liver injury depends on proper selection of laboratory and imaging tests. Review the best diagnostic tools in this article.
  Liver International, February 04, 2020